Regeneron Pharmaceuticals Inc (REGN)
906.80
-0.10
(-0.01%)
USD |
NASDAQ |
Apr 24, 16:00
906.80
0.00 (0.00%)
After-Hours: 19:07
Regeneron Pharmaceuticals Price: 906.80 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 905.66 | 912.74 | 903.83 | 906.91 | 257776.0 |
| Apr 22, 2024 | 904.54 | 908.67 | 897.45 | 900.16 | 351366.0 |
| Apr 19, 2024 | 913.97 | 920.73 | 891.46 | 896.82 | 507466.0 |
| Apr 18, 2024 | 901.26 | 908.81 | 891.67 | 893.99 | 450630.0 |
| Apr 17, 2024 | 903.88 | 911.64 | 899.90 | 901.19 | 468668.0 |
| Apr 16, 2024 | 897.22 | 901.06 | 890.43 | 894.14 | 615756.0 |
| Apr 15, 2024 | 915.37 | 921.12 | 895.09 | 898.56 | 656427.0 |
| Apr 12, 2024 | 911.55 | 912.22 | 898.26 | 904.70 | 665281.0 |
| Apr 11, 2024 | 928.58 | 930.64 | 907.33 | 920.32 | 617176.0 |
| Apr 10, 2024 | 935.02 | 937.87 | 923.44 | 936.20 | 389765.0 |
| Apr 09, 2024 | 941.39 | 949.20 | 938.00 | 943.89 | 305901.0 |
| Apr 08, 2024 | 939.16 | 942.98 | 935.51 | 938.48 | 330917.0 |
| Apr 05, 2024 | 939.31 | 949.83 | 934.87 | 942.70 | 363545.0 |
| Apr 04, 2024 | 962.20 | 962.20 | 935.36 | 937.02 | 410837.0 |
| Apr 03, 2024 | 955.00 | 961.68 | 950.43 | 950.95 | 413251.0 |
| Apr 02, 2024 | 961.44 | 961.44 | 951.02 | 954.68 | 438124.0 |
| Apr 01, 2024 | 964.73 | 970.20 | 954.09 | 969.31 | 360696.0 |
| Mar 28, 2024 | 970.38 | 970.79 | 959.25 | 962.49 | 461867.0 |
| Mar 27, 2024 | 971.04 | 976.75 | 962.41 | 966.30 | 314755.0 |
| Mar 26, 2024 | 961.99 | 966.68 | 957.78 | 963.55 | 386837.0 |
| Mar 25, 2024 | 954.01 | 964.98 | 952.47 | 961.09 | 322288.0 |
| Mar 22, 2024 | 973.00 | 977.39 | 966.47 | 967.24 | 274406.0 |
| Mar 21, 2024 | 974.75 | 979.26 | 968.00 | 968.01 | 435147.0 |
| Mar 20, 2024 | 959.06 | 967.20 | 947.37 | 966.96 | 579358.0 |
| Mar 19, 2024 | 965.11 | 969.16 | 959.14 | 963.66 | 365329.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
273.46
Minimum
Sep 27 2019
993.35
Maximum
Feb 27 2024
609.17
Average
612.53
Median
Price Benchmarks
| Vertex Pharmaceuticals Inc | 400.73 |
| Eli Lilly and Co | 731.88 |
| AbbVie Inc | 167.89 |
| Amgen Inc | 273.12 |
| Pfizer Inc | 26.28 |
Price Related Metrics
| PE Ratio | 26.10 |
| PS Ratio | 7.864 |
| Price to Book Value | 3.832 |
| Price to Free Cash Flow | 28.12 |
| Earnings Yield | 3.83% |
| Market Cap | 99.53B |
| Operating PE Ratio | 24.37 |
| Normalized PE Ratio | 23.65 |